Pill imprint M 89 has been identified as Meloxicam 15 mg.
Meloxicam is used in the treatment of osteoarthritis; rheumatoid arthritis; juvenile rheumatoid arthritis; tendonitis; fibromyalgia (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. Risk cannot be ruled out during pregnancy.
Meloxicam 15 mg is not subject to the Controlled Substances Act.
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 26 Sep 2017 • 1 answer
Posted 14 Nov 2017 • 1 answer
Posted 16 Dec 2017 • 0 answers
Posted 28 Dec 2017 • 1 answer
Posted 14 days ago • 1 answer